Hiatal hernia repair with transoral incisionless fundoplication versus Nissen fundoplication for gastroesophageal reflux disease: A retrospective study

Abstract

Background and study aims Concomitant hiatal hernia (HH) repair with transoral incisionless fundoplication (TIF) is a therapeutic option for patients with HH > 2 cm and gastroesophageal reflux disease (GERD). Data comparing this approach with laparoscopic Nissen fundoplication (LNF) are lacking. We performed an exploratory analysis to compare these two approaches' adverse events (AEs) and clinical outcomes.

Patients and methods This was a multicenter retrospective cohort study of HH repair followed by LNF versus HH repair followed by TIF in patients with GERD and moderate HH (2–5 cm). AEs were assessed using the Clavien-Dindo classification. Symptoms (heartburn/regurgitation, bloating, and dysphagia) were compared at 6 and 12 months.

Results A total of 125 patients with HH repair with TIF and 70 with HH repair with LNF were compared. There was no difference in rates of discontinuing or decreasing proton pump inhibitor use, dysphagia, esophagitis, disrupted wrap, and HH recurrence between the two groups (P > 0.05). The length of hospital stay (1 day vs. 2 days), 30-day readmission rate (0 vs. 4.3 %), early AE rate (0 vs. 18.6 %), and early serious AE rate (0 vs. 4.3 %) favored TIF (all P < 0.05). The rate of new or worse than baseline bloating was lower in the TIF group at 6 months (13.8 % vs. 30.0 %, P = 0.009).

Conclusions Concomitant HH repair with TIF is feasible and associated with lower early and serious AEs compared to LNF. Further comparative efficacy studies are warranted.

Publikationsverlauf

Eingereicht: 24. März 2022

Angenommen nach Revision: 19. Oktober 2022

Artikel online veröffentlicht:
04. Januar 2023

• References

• 1 El-Serag HB, Sweet S, Winchester CC. et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014; 63: 871-880
• 2 Ronkainen J, Aro P, Storskrubb T. et al. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther 2006; 23: 1725-1733
• 3 Sontag SJ, Sonnenberg A, Schnell TG. et al. The long-term natural history of gastroesophageal reflux disease. J Clin Gastroenterol 2006; 40: 398-404
• 4 Bruley des Varannes S, Lofman HG, Karlsson M. et al. Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France. BMC Gastroenterol 2013; 13: 39
• 5 Nehra AK, Alexander JA, Loftus CG. et al. Proton pump inhibitors: review of emerging concerns. Mayo Clinic proceedings 2018; 93: 240-246
• 6 Scholten T. Long-term management of gastroesophageal reflux disease with pantoprazole. Ther Clin Risk Manag 2007; 3: 231-243
• 7 El-Serag H, Becher A, Jones R. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther 2010; 32: 720-737
• 8 Grigolon A, Cantu P, Savojardo D. et al. Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients. J Clin Gastroenterol 2008; 42: 969-973
• 9 Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut 2009; 58: 295-309
• 10 Nijjar RS, Watson DI, Jamieson GG. et al. Five-year follow-up of a multicenter, double-blind randomized clinical trial of laparoscopic Nissen vs anterior 90 degrees partial fundoplication. Arch Surg 2010; 145: 552-557
• 11 Cookson R, Flood C, Koo B. et al. Short-term cost effectiveness and long-term cost analysis comparing laparoscopic Nissen fundoplication with proton-pump inhibitor maintenance for gastro-oesophageal reflux disease. Br J Surgery 2005; 92: 700-706
• 12 Lundell L, Miettinen P, Myrvold HE. et al. Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis. Br J Surgery 2007; 94: 198-203
• 13 Mahon D, Rhodes M, Decadt B. et al. Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux. Br J Surgery 2005; 92: 695-699
• 14 Tian ZC, Wang B, Shan CX. et al. A meta-analysis of randomized controlled trials to compare long-term outcomes of Nissen and Toupet fundoplication for gastroesophageal reflux disease. PLoS One 2015; 10: e0127627
• 15 Bazerbachi F, Krishnan K, Abu Dayyeh BK. Endoscopic GERD therapy: a primer for the transoral incisionless fundoplication procedure. Gastrointest Endosc 2019; 90: 370-383
• 16 Trad KS, Barnes WE, Prevou ER. et al. The TEMPO Trial at 5 Years: transoral fundoplication (tif 2.0) is safe, durable, and cost-effective. Surg Innov 2018; 25: 149-157
• 17 Gerson L, Stouch B, Lobontiu A. Transoral incisionless fundoplication (TIF 2.0): a meta-analysis of three randomized, controlled clinical trials. Chirurgia (Bucur) 2018; 113: 173-184
• 18 Pandolfino JE. Hiatal hernia and the treatment of acid-related disorders. Gastroenterol Hepatol (NY) 2007; 3: 92-94
• 19 Avidan B, Sonnenberg A, Schnell TG. et al. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol 2002; 97: 1930-1936
• 20 Cameron AJ. Barrett's esophagus: prevalence and size of hiatal hernia. Am J Gastroenterol 1999; 94: 2054-2059
• 21 Jones MP, Sloan SS, Rabine JC. et al. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease. Am J Gastroenterol 2001; 96: 1711-1717
• 22 Ihde GM, Besancon K, Deljkich E. Short-term safety and symptomatic outcomes of transoral incisionless fundoplication with or without hiatal hernia repair in patients with chronic gastroesophageal reflux disease. Am J Surgery 2011; 202: 740-746 ; discussion 746–747
• 23 Chang CG, Thackeray L. Laparoscopic hiatal hernia repair in 221 patients: outcomes and experience. JSLS 2016; 20: e2015.00104
• 24 Janu P, Shughoury AB, Venkat K. et al. Laparoscopic hiatal hernia repair followed by transoral incisionless fundoplication with EsophyX device (HH + TIF): efficacy and safety in two community hospitals. Surg Innov 2019; 26: 675-686
• 25 Gisi C, Wang K, Khan F. et al. Efficacy and patient satisfaction of single-session transoral incisionless fundoplication and laparoscopic hernia repair. Surg Endosc 2020; 35: 921-927
• 26 Ihde 2nd GM , Pena C, Scitern C. et al. pH scores in hiatal repair with transoral incisionless fundoplication. JSLS 2019; 23: e2018.00087
• 27 Stefanidis D, Hope WW, Kohn GP. et al. Guidelines for surgical treatment of gastroesophageal reflux disease. Surg Endosc 2010; 24: 2647-2669
• 28 Bell RC, Cadiere GB. Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations. Surg Endosc 2011; 25: 2387-2399
• 29 Jobe BA, O'Rourke RW, McMahon BP. et al. Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Ann Surg 2008; 248: 69-76
• 30 Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213
• 31 Wang K, Khan F, Hou LA. et al. Efficacy of combined transoral incisionless fundoplication and laparaoscopic hiatal hernia repair. Gastrointest Endosc 2018; 87: AB254-AB255
• 32 Frazzoni M, Conigliaro R, Manta R. et al. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther 2011; 34: 67-75
• 33 Richter JE, Kumar A, Lipka S. et al. Efficacy of laparoscopic nissen fundoplication vs transoral incisionless fundoplication or proton pump inhibitors in patients with gastroesophageal reflux disease: a systematic review and network meta-analysis. Gastroenterology 2018; 154: 1298-1308
• 34 Abu Dayyeh B, Murad MH, Bazerbachi F. et al. Efficacy of laparoscopic Nissen fundoplication vs transoral incisionless fundoplication or proton pump inhibitors in patients with gastroesophageal reflux disease: misleading ranking probabilities in network meta-analysis. Gastroenterology 2018; 155: 935-936
• 35 Hakansson B, Montgomery M, Cadière GB. et al. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD. Aliment Pharmacol Ther 2015; 42: 1261-1270
• 36 Hunter JG, Kahrilas PJ, Bell RC. et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology 2015; 148: 324-333
• 37 Witteman BP, Conchillo JM, Rinsma NF. et al. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Am J Gastroenterol 2015; 110: 531-542
• 38 Chimukangara M, Jalilvand AD, Melvin WS. et al. Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study. Surg Endosc 2019; 33: 1304-1309
• 39 Stefanidis G, Viazis N, Kotsikoros N. et al. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy. Dis Esophagus 2017; 30: 1-8
• 40 Testoni PA, Testoni S, Mazzoleni G. et al. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc 2015; 29: 2770-2780
• 41 Du X, Hu Z, Yan C. et al. A meta-analysis of long follow-up outcomes of laparoscopic Nissen (total) versus Toupet (270 degrees ) fundoplication for gastro-esophageal reflux disease based on randomized controlled trials in adults. BMC Gastroenterol 2016; 16: 88
• 42 Furnee EJ, Draaisma WA, Broeders IA. et al. Surgical reintervention after failed antireflux surgery: a systematic review of the literature. J Gastrointest Surg 2009; 13: 1539-1549
• 43 Ashfaq A, Rhee HK, Harold KL. Revision of failed transoral incisionless fundoplication by subsequent laparoscopic Nissen fundoplication. World J Gastroenterol 2014; 20: 17115-17119
• 44 Bell RC, Kurian AA, Freeman KD. Laparoscopic anti-reflux revision surgery after transoral incisionless fundoplication is safe and effective. Surg Endosc 2015; 29: 1746-1752
• 45 Perry KA, Linn JG, Eakin JL. et al. Transoral incisionless fundoplication does not significantly increase morbidity of subsequent laparoscopic Nissen fundoplication. J Laparoendosc Adv Surg Tech A 2013; 23: 456-458